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K2P channelsMany functions of T lymphocytes are closely related to cell volume homeostasis and regulation, which utilize
a complex network of membrane channels for anions and cations. Among the various potassium channels,
the voltage-gated KV1.3 is well known to contribute greatly to the osmoregulation and particularly to the
potassium release during the regulatory volume decrease (RVD) of T cells faced with hypotonic environment.
Here we address a putative role of the newly identiﬁed two-pore domain (K2P) channels in the RVD of human
CD4+ T lymphocytes, using a series of potent well known channel blockers. In the present study, the pharma-
cological proﬁles of RVD inhibition revealed K2P5.1 and K2P18.1 as the most important K2P channels involved
in the RVD of both naïve and stimulated T cells. The impact of chemical inhibition of K2P5.1 and K2P18.1 on the
RVD was comparable to that of KV1.3. K2P9.1 also notably contributed to the RVD of T cells but the extent of
this contribution and its dependence on the activation status could not be unambiguously resolved. In
summary, our data provide ﬁrst evidence that the RVD-related potassium efﬂux from human T lymphocytes
relies on K2P channels.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Volume regulation is a basic property of mammalian cell types and
tissues, including T cells of the immune system [1–3]. Volume regula-
tory mechanisms are challenged by a variety of factors, such as
changes in extracellular tonicity, membrane channel activity and
cellular metabolism, as well as during cell proliferation, mitogen
stimulation and apoptosis [4,5]. Numerous studies have also demon-
strated the importance of volume regulation in various physiological
and pathophysiological conditions, e.g. inﬂammation, etc. (for review
see Ref. [6]).
A large body of literature now exists on the osmotic volume
regulation in T lymphocytes and other subtypes of lymphoid cells
[7,8]. Even under continuous hypotonic conditions, T lymphocytes
can re-adjust their normal isotonic volume after transient swelling, Department of Neurology—
ooncology, Germany.
Meuth),
kov).
rights reserved.by a mechanism known as regulatory volume decrease (RVD). During
RVD, the cell swelling causes co-activation of volume-sensitive
chloride and various potassium channels. This leads to the net potassium
chloride efﬂux, osmotic water loss and to the restoration of normal cell
volume [6,9].
Voltage-gated potassium channels (KV1.3) have been found to be
essential for the volume regulation in T lymphocytes [10,11]. Addition-
ally, several alternative pathways have been suggested to contribute to
the RVD in lymphocytes, including calcium activated potassium chan-
nels (KCa3.1) [12], TRPM7 channels [13], swelling-activated channels
for small organic osmolytes [14] and two-pore domain potassium chan-
nels, K2P [3].
The family of K2P channels is the most recently described potassium
channel family expressed on T lymphocytes [15,16]. In a previous study
involving K2P channel knockouts and pharmacological inhibitors [3], we
have identiﬁed the leading role of K2P5.1 in the RVD of murine T cells,
with a smaller contribution of K2P3.1, K2P9.1 and K2P18.1. Unfortunately,
differences in the K+ channel expression proﬁles between murine and
human cells, alongwith the broad variations in expression levels during
T cell differentiation and activation do not allow a direct transfer of our
previous murine results to the human system [15–18].
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of various K2P channels to the hypotonic volume regulation of human
CD4+ T lymphocytes, using a pharmacological approach. To this end,
we analyzed the sensitivity of the RVD in human T cells (including
both naïve and stimulated cells) to different well known potassium
channel blockers by video microscopy.
2. Materials and methods
2.1. Cell isolation and incubation
Human T lymphocytes were isolated from the peripheral blood of
healthy donors, which was provided from the institute of transfusion
medicine and hemotherapy of the university clinic in Wuerzburg.
Peripheral blood mononuclear cells (PBMCs) were collected by densi-
ty gradient centrifugation using a lymphocyte separation medium
(PAA Laboratories, Pasching, Austria). CD4+ T lymphocytes were sep-
arated bymagnetic cell sorting (MACS), using human CD4 isolation kit
II (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the
manufacturer's instructions. Isolated CD4+ T cells (~90% purity by
FACS) were incubated in T cell medium (RPMI1640, 10% human AB
serum, 1% penicillin/streptomycin, 1% glutamine) for 48 h with or
without stimulation. T cells were stimulated for 48 h with CD3/CD28
human T activator dynabeads in a cell to bead ratio of 4:1 (Invitrogen,
Darmstadt, Germany), at 37 °C, 5% CO2. The research protocol was
approved by the local ethics committee (AZ.: 2011-150-f-S).
2.2. Western blot
T lymphocytes were isolated and incubated as described above.
2×106 cells (either naïve or stimulated) were lysed in 30 μl lysis
buffer (1% NP-40, 10% n-dodecyl-β-D-maltoside, 1 mM sodium
monovanadate, 1 mM PMSF, 50 μM TRIS, 10 mM NaF, 10 mM
EDTA and 165 mM NaCl) 20 min on ice. After 10 min centrifugation
at 18000 rcf and 4 °C the supernatant was mixed with 7.5 μl sample
buffer (20 mM TRIS, 10% glycerol, 0.05% bromphenolblue and 1%
SDS) and heated 5 min at 99 °C. The proteins were separated on a
10% SDS–PAGE and transferred to a nitrocellulose membrane. Mem-
branes were blocked with 5% dry milk and probed with the
following antibodies: anti K2P3.1 (1:500, Santa Cruz, sc-32067,
46 kDa), anti K2P5.1 (1:1000, Sigma Aldrich, P 1106, 70 kDa), anti
K2P9.1 (1:500, Santa Cruz, sc-11320, 75 kDa), anti K2P18.1 (1:1000,
Santa Cruz, sc-51237, 43 kDa) and KV1.3 (1:1000, Sigma Aldrich,
P4497, 110 kDa). All antibodies were diluted in 5% BSA and incubat-
ed over night at 4 °C. The corresponding horseradish-peroxidase
conjugated secondary antibody (Santa Cruz) was diluted 1:3000 in
5% dry milk and incubated 1 h at room temperature. The antibody
reaction was detected by enhanced chemiluminescence reaction
(ECL, Amersham Biosciences). The analysis was done using image
J software.
2.3. Electrophysiological measurements
Human CD4+ T lymphocytes were isolated from buffy coats using
the RosettSep® “human CD4+ T cell enrichment cocktail” according to
themanufacturer's instructions (Stemcell technologies, Köln, Germany).
Isolated CD4+ T cells were either left unstimulated or cultured in well
plates coated with 2 μg/ml anti-human CD3 antibodies (clone 2C11,
BD Pharmingen) and 1 μg/ml soluble anti-human CD28 antibodies
(clone 28.2, BD Pharmingen) for T cell receptor stimulation. All
patch-clamp measurements were conducted in the whole-cell conﬁgu-
ration 24 to 48 h after T cell isolation. Recordingpipetteswere fabricated
from borosilicate glass (GT150TF-10, Clark Electromedical Instruments,
Pangbourne, UK; typical resistance was 6–7 MΩ) and ﬁlled with an
intracellular solution containing (in mM): K-gluconate, 88; K3-citrate,
20; phosphocreatine, 15; NaCl, 10; HEPES, 10; MgCl2, 1; CaCl2, 0.5;BAPTA, 3; Mg-ATP, 3; Na3-GTP, 0.5. The internal solution was set to a
pH of 7.25 with KOH and an osmolality of 295 mosm/kg. Since the
whole-cell patch-clamp conﬁguration is accompanied by a loss of cyto-
solic compounds, the internal solution includes energy sources (phos-
phocreatine, Mg-ATP, Na3-GTP), Ca2+ buffers (citrate, BAPTA), a pH
buffer (HEPES), and different salts for physiological ionic conditions. Ex-
tracellular solution contained (in mM): NaCl, 125; KCl, 2.5; NaH2PO4,
1.25; HEPES, 30; MgSO4, 2; CaCl2, 2; glucose, 10; pH 7.35 and osmolality
was set to 305 mosm/kg. Membrane currents were recorded using a
EPC-10 ampliﬁer, and digital analysis was done using Fitmaster software
(HEKA Elektronik, Lamprecht, Germany [18]). From a holding potential
of −80 mV outward currents were elicited by 0.5 s rectangular pulses
to +40 mV, applied at 30 s intervals. Outward currents under control
conditions and drug application were recorded successively from identi-
cal cells.
2.4. Channel blockers
Channel blockers were purchased from Sigma (Germany), except
ShK, which was from Bachem AG (Switzerland), and A293 kindly pro-
vided by Sanoﬁ Aventis (Frankfurt, Germany, [19]). The blockers were
used at the following concentrations: anandamide 3, 30 and 100 μM
(targeting primarily K2P3.1, and at higher concentrations also
K2P9.1); A293 1, 3 and 10 μM (K2P3.1, K2P9.1); quinidine 2, 20,
100 μM (K2P5.1, K2P18.1); bupivacaine 3, 30, 300 μM (K2P18.1,
K2P3.1/5.1/9.1), spermine 100, 500 and 1000 μM (K2P9.1), ruthenium
red 10, 100, 1000 μM (K2P9.1), ShK 1, 10, 100 nM (KV1.3). For a par-
ticular channel blocker, the intermediate concentration corresponded
to that reported in the literature as a concentration of maximum
inhibition.
2.5. Cell volumetry
Cell volume changes were quantiﬁed by video microscopy using
the experimental setup described previously [3,14]. Before measure-
ment, a channel blocker was added to 1 ml of human CD4+ T lympho-
cytes suspended in T cell medium at a density of about 2×105 cells/ml.
The cell suspension was then injected into the polydimethylsiloxane
(PDMS) ﬂow chamber. The chamber was sealed with a poly-D-lysine
coated coverslip (0.5 mg/ml poly-D-lysine, Sigma, 5–10 min) and
placed on a microscope slide. To allow cell adhesion on the coverslip
the ﬂow chamber was incubated upside down for about 15 min. The
cells were observed with a 20× objective in transmitted light using a
microscope (Axiophot, Zeiss, Germany) equipped with a CMOS video
camera (UI-1440-C, UEye, Obersulm, Germany). Images were taken
at a time interval of 10 s containing typically 10–20 cells. Thirty
seconds after start of the measurement the cell culture medium was
exchanged by hypotonic (200 mOsm), isotonic (300 mOsm) or
hypertonic (400 mOsm) PBS using a syringe pump (KDS100, KD
Scientiﬁc, Holliston, USA) with a ﬂow rate of about 1 ml/min. Hypo-
and hypertonic PBS solutions were prepared by dilution of 10×
Dulbecco's PBS (without Ca2+ or Mg2+; PAA, Linz, Austria) with ap-
propriate amounts of deionized water from a Milli-Q puriﬁcation
system (Millipore, Schwalbach, Germany). The solution osmolality
(mosmol/kg) was veriﬁed using a cryoscopic osmometer (Osmomat
010, Gonotec, Berlin, Germany).
The cell volume (V) of a single cell at each time interval was calcu-
lated from its cross section area determined with the aid of the image
analysis software ImageJ (Wayne Rasband, NIH, Maryland, USA), by
assuming spherical geometry. The cell volume was normalized to
the isotonic cell volume (V0) as: ν=V/V0. The mean ν values with
corresponding standard errors from a sequence of about 120 images
were plotted against time.
To estimate the osmotically inactive fraction in untreated naïve
and stimulated CD4+ T lymphocytes, the experimental normalized
cell volume 2 min after measurement start (ν2) was plotted against
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Fig. 1. Changes in the isotonic radius of human CD4+ T lymphocytes induced by T cell
receptor stimulation using CD3/CD28 dynabeads (A) and by various concentrations of
potassium channel blockers (B). The histograms in A show cell size distributions in
naïve and stimulated cell samples (dashed and gray bars, respectively) analyzed by
video microscopy. Naïve and stimulated cells exhibit mean radii (±SD) of 3.6±
0.2 μm (N=350 cells) and 5.6±1.1 μm (N=950 cells), respectively. Curves are best
Gaussian ﬁts to the data. In B: isotonic incubation of naïve T lymphocytes with the
potassium channel blockers anandamide (Ana), A293, ruthenium red (RR), spermine
(Spe), quinidine (Qui), bupivacaine (Bup) and ShK led to a volume increase. All samples
were bathed in isotonic CGM (~300 mOsm) supplemented with the indicated blocker
concentrations for ~15 min at room temperature. The mean radii (±SE) of the cells
were calculated from the cross-section areas of 40–140 individual cells measured in
3–16 independent experiments. The dotted line shows the mean isotonic radius of
the untreated control. Except the lowest concentrations of Ana and A293 (indicated
by n.s.=not signiﬁcant), all treatments gave rise to statistically signiﬁcant increases
(Pb0.05) of cell radius. The corresponding data of stimulated cells are given in the
Supplement (Fig. S1).
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400 mOsm and ﬁtted by the Boyle van't Hoff equation:
v2 ¼
Ciso
C
1−bð Þ þ b ð1Þ
where C is the PBS osmolality and Ciso=300 mOsm is the isotonic
osmolality. The term b ¼ VbV0 represents the osmotically inactive
volume fraction at 300 mOsm. The linear regression of Eq. (1) to the
volumetric data yielded very similar estimates of the osmotically
inactive fraction for naive and stimulated CD4+ T lymphocytes.
2.6. Analysis of volumetric data
The effects of potassium channel blockers on hypotonic volume
regulation of human CD4+ T lymphocytes were analyzed by the
following equation for the RVD inhibition index (ICRVD):
ICRVD ¼ 1−
v2−vend
v2−vcotrend
 !
 100% ð2Þ
Symbol ν2 stands for the normalized cell volume at the maximum
swelling level achieved ~2–3 min after hypotonic exposure, as illus-
trated in Fig. 4 below. Symbol νend denotes the normalized cell
volume measured 17–20 min after hypotonic shock, for cells pre-
treated with a channel blocker. The νend values of untreated controls
are given by vendcotr. In treated cell samples, no RVD inhibition (ICRVD=
0) was observed if their volume restoration was similar to that of
untreated control (vend=vendcotr). In contrast, cells showed ICRVD of
100% if they were incapable of volume restoration and remained
swollen in hypotonic medium (vend=v2). Standard errors of ν2, νend
and ICRVD were calculated using Gaussian error propagation.
3. Results and discussion
3.1. Isotonic cell volume changes
T cell receptor stimulation is well known to alter signiﬁcantly the
expression pattern of ion channels in human T lymphocytes, which in
turn can markedly affect their electrophysiological, osmotic and other
biophysical properties [17,20]. Therefore, this study involved experi-
ments with naïve (unstimulated) and T cell receptor stimulated T
cells. As seen in Fig. 1A, the T cell radius increased markedly (i.e. by
~60%) from 3.6±0.2 μm (mean±SD) to 5.6±1.1 μm upon stimula-
tion with CD3/CD28 coated beads. This change of the cell radius corre-
sponds to a nearly 4-fold increase in the absolute cell volume.
Moreover, judging by the coefﬁcients of variation, CV (calculated as
CV=SD/mean), T cell receptor stimulation also yielded amuch broader
population distribution of cell radii (CV=20%), as compared to naïve T
cells (~6%).
Prior to exposure of T cells to anisotonic stress, we analyzed the ef-
fects of potassium channel blockers on the cell volume under isotonic
conditions. As seen in Fig. 1B, all tested channel blockers slightly in-
creased the radius of naïve T cells by up to ~6%, which corresponded
to a cell volume increase by ~18%. The observed isotonic cell swelling
might have resulted from an elevated potassium concentration in the
cytosol (and subsequent water inﬂux) caused by the chemical block-
ade of potassium channels in the plasma membrane that are open
under control conditions. In case of stimulated cells (see supplemen-
tary Fig. S1), the channel blockers caused less signiﬁcant changes in
isotonic cell radii, apparently because of a much greater size variation.
Whatever the explanation, the data in Fig. 1B provide clear evidence
for the importance of potassium channels in maintaining the T cell
volume under physiological conditions.3.2. Cell volume changes and regulation in anisotonic media
Irrespective of the activation status, a sudden exposure of T cells to
hypotonic or hypertonic solutions caused T cells to either swell or
shrink rapidly within 2–3 min due to the water movement driven
by the imposed osmotic gradients (Fig. 2A and B). Despite the great
difference in their isotonic radii (Fig. 1A), naïve and stimulated
lymphocytes exhibited very similar relative volume changes in
response to anisotonic media. In both cell samples, the hypotonic
PBS (200 mOsm) gave rise to a rapid transient increase of the cell vol-
ume to closely similar maximum ν2 values of ~1.2. After the fast ini-
tial swelling, both cell types slowly underwent regulatory volume
decrease (RVD), but without reaching the original isotonic cell vol-
ume within 20 min. The long-term ν values (νend) measured after
~20 min incubation were also similar, i.e. ~1.05 and ~1.07 in naive
and stimulated T cells, respectively.
In contrast to the hypotonic volume regulation, both cell types
were incapable of undergoing regulatory volume increase (RVI) in
hypertonic 400 mOsm PBS (ﬁlled symbols in Fig. 2A and B). More-
over, stimulated T cells shrank continuously to vend=0.72 over the
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Fig. 2. Temporal changes of the normalized cell volume V/V0 in naïve and stimulated
human T cells (A and B, respectively) in response to PBS of varying osmolalities. All cell
samples were bathed initially in isotonic CGM (~300 mOsm) and then exposed (at t=
30 s) to PBS having osmolalities of 200 (open circles), 300 (triangles) or 400 mOsm (ﬁlled
circles). Under hypotonic conditions (200 mOsm PBS, gray circles), both naïve and stim-
ulated cells ﬁrst swelled rapidlywithin 2–3 min and then slowly underwent RVD. Isotonic
PBS caused only little volume changes. In response to hypertonic solutions with the tonic-
ity of 400 mOsm the cells shrank rapidly during the ﬁrst 2–3 min. After that, the cell
volume either remained unchanged (A) or slowly decreased (B). The initial cell volume
is given by ν0=1. Symbols ν2 stands for the normalized cell volume observed ~2 min
after medium exchange. Each data point represents themean ν±SE of 40–120 individual
cells measured in 4–16 independent experiments. In C: the mean ν2 values of the initial
volume changes are plotted against the reciprocal normalized osmolality (Ciso/C, where
Ciso=300 mOsm), for naïve (open circles) and stimulated T lymphocytes (ﬁlled circles).
The lines are best least-square ﬁts of the van't Hoff equation (Eq. (1)) to the data. The
osmotically inactive volume fractions (b), deﬁned by the Y-intercepts, were found to be
0.61±0.04 for quiescent and 0.54±0.07 stimulated cells.
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reported here corroborates previous ﬁndings of RVI incapability in
lymphoid cells, e.g. human blood lymphocytes, mouse T lymphocytes,
etc. [3,11,21].
To evaluate the impact of T cell receptor stimulation on the osmot-
ically inactive volume fraction, we analyzed the initial volume
responses of naïve and stimulated T cells with the Boyle van't Hoff
equation (Eq. (1)). Fig. 2C shows the experimental ν2 values of both
cell types plotted versus the reciprocal normalized osmolality Ciso/C
(symbols in Fig. 2C) over the osmolality range between 200 and
400 mOsm. The linear regression of Eq. (1) to the data yielded slightlydifferent estimates of the osmotically inactive fraction for naïve (b=
0.61±0.04) and stimulated T cells (b=0.54±0.07).
3.3. Inﬂuence of K2P channel inhibition on membrane currents and RVD
In the following electrophysiological experiments, we ﬁrst proved
the presence of functional K2P channels in the plasma membrane of
naïve and stimulated T cells. Fig. 3A–H show representative patch-
clamp recordings (whole-cell conﬁguration) in the presence of vari-
ous potassium channel blockers. All tested channel blockers caused
a detectable current reduction in both naïve and stimulated T lym-
phocytes, suggesting that relevant potassium channels were func-
tionally expressed on T cells.
Additionally, potassium channel expression in naïve and stimulated
T lymphocytes was quantitatively evaluated by western blot. As seen in
Fig. 3I and J, T cell receptor stimulation caused upregulation of K2P3.1,
K2P5.1 and KV1.3. In contrast, the expression levels of K2P9.1 and
K2P18.1 were similar in naïve and stimulated T lymphocytes.
Given that neither naive nor stimulated human T cells were capable
of volume regulation in hypertonic PBSmedia (ﬁlled symbols in Fig. 2),
the following experimentswere restricted tomild hypotonic conditions
(200 mOsm PBS). To analyze the effects of channel blockers on RVDwe
calculated the RVD inhibition indexes (ICRVD, Eq. (2)) using the ν2 and
νend values derived from the volumetric data, such as illustrated in
Fig. 4.
3.4. Inhibition of K2P3.1 and K2P9.1
The endocannabinoid anandamide has been reported as a potent
inhibitor of several K2P channels [22,23]. Within the concentration
range of 3–30 μM anandamide is known to preferentially target
K2P3.1, whereas at 100 μM it additionally inhibits K2P9.1 in COS-7
cells [24].
In the present study, anandamide (3, 30 and 100 μM) exerted
similar effects on the volume regulation in T cells, independently of
the stimulation status. This result suggests that the relative contribu-
tion of K2P3.1 channels to RVD had been unaffected by stimulation
with CD3/CD28 beads, despite an ~threefold upregulation of the
channel revealed by western blot (see Fig. 3I and J). 30 μM ananda-
mide inhibited the hypotonic volume regulation in both cell types
by ~40% (Fig. 4), which implies a notable contribution of K2P3.1 to
the RVD process. Furthermore, increasing the anandamide concentra-
tion to 100 μM strongly enhanced the RVD inhibition in human T cells
(~110 and 80%, in naïve and stimulated cells, respectively), apparent-
ly, due to the simultaneous blockade of K2P3.1 and K2P9.1 (see also
Supplementary Table 1). These data indicate a major contribution of
K2P3.1 and K2P9.1 channels in the orchestration of RVD.
The following experiments involving A293, a more selective blocker
of K2P3.1, further supported the importance of this K2P channel for the
RVD in human T cells. A293 has been reported to block human K2P3.1
by 50% at a concentration of 222 nM [25]. This substance is therefore
the ﬁrst K2P3.1 channel inhibitor acting at submicromolar concentra-
tions. At higher concentrations, A293 additionally inhibits K2P9.1 [25].
As seen in Fig. 5, naïve and stimulated T cells exhibited a compara-
ble RVD inhibition (by ~30–40%) upon treatment with A293 over the
entire concentration range (1–10 μM). In view of the partial RVD
inhibition, this ﬁnding corroborates the results with anandamide
(Fig. 4), thus conﬁrming a signiﬁcant (but not sole) contribution of
K2P3.1 to the RVD in human T cells. Although unspeciﬁc channel inhi-
bition at higher concentrations of anandamide and A293 cannot be
strictly excluded, our results point to K2P9.1 as an additional channel
involved in the RVD of human T cells.
To address directly the role of K2P9.1 in RVD, we ﬁrst analyzed the
RVD responses of T cells in the presence of ruthenium red (RR) which
is well known for its ability to block K2P9.1 channels [26,27]. In sharp
contrast to the effects of anandamide and A293, the inhibitory effect
K2P3.1
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Fig. 3. Functional expression of K2P3.1, K2P5.1, K2P9.1, K2P18.1 and KV1.3 on naïve and stimulated human T lymphocytes, probed by patch clamp (A–H) and western blot (I and J). Elec-
trophysiological recordings with naïve and stimulated T lymphocytes show the outward currents in control (black lines) and drug-treated cells (gray lines): (A) A293, (B) anandamide,
(C) ruthenium red, (D) spermine, (E) bupivacaine, (F) quinidine and (G) ShK. All blockers caused a noticeable current reduction pointing to the functional expression of the targeted
potassiumchannel (n=3, one representative example is shown for each condition). (H) Patch clampprotocol and legend. Parts (I) and (J) show the expression levels of various potassium
channels in naïve (black bars) and stimulated (gray bars) T lymphocytes, analyzed by western blot.
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In naïve T cells, RR caused a near complete RVD inhibition (by ~75–85%)
over the entire concentration range (Fig. 5A). T cell receptor stimulation
decreased markedly the RVD inhibition capacity of RR to 25–45%
(Fig. 5B). In naive cells, the inhibitory effect on RVD was found to be
quite independent of the RR concentration (probably due to saturation
of the target channel), at least within the range (10 μM–1 mM) used
here. Although interactions of RR with other targets, e.g. ryanodinereceptors, [28], cannot be fully ruled out, the observed differences in
the RR-mediated RVD inhibition, despite comparable expression levels
(Fig. 3J), might have been resulted from a greater relative contribution
of K2P9.1, probed with RR, to volume regulation in naïve cells.
To further prove the importance of K2P9.1 in RVD,we treated T cells
with spermine, a naturally occurring organic polyamine targeting spe-
ciﬁcally K2P9.1. In earlier electrophysiological experiments performed
on thalamocortical relay neurons [26], 100 μM spermine has been
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maximum swelling level (t=2 min), and the ﬁnal volume averaged over the time interval
of 15–20 min after medium exchange. Substituting the ν2 and νend data measured in the
volumetric experiments into Eq. (2) yielded the values of the RVD inhibition index for
anandamide (and other channel blockers, see supplement Table S1).
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Fig. 5. The inhibitory effects of potassium channel blockers on RVD in naïve (A) and
stimulated human T lymphocytes (B). All treated samples and untreated controls were
subjected to the same hypotonic stress in 200 mOsm PBS and analyzed by volumetry as
illustrated in Fig. 4. For each blocker concentration, the extent of RVD inhibition was calcu-
lated from the corresponding ν2 and νend data (summarized in Suppl. Table S1) by applying
Eq. (2). Note that naïve T cells treated with the highest anandamide concentration
(100 μM) were incapable of volume regulation (i.e. remained swollen, see also Fig. 4A)
and exhibited a RVD inhibition of ~100%. In contrast, 3 μM anandamide did not impair
signiﬁcantly RVD in naïve cells (RVD inhibition=0).
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study, spermine led to a modest RVD inhibition (~25%) in naïve
cells, independent of concentration (0.1–1 mM). In stimulated cells,
the RVD inhibition enhanced slightly from 55 to 65%, as the spermine
concentration was increased for 100 μM to 1 mM.
The above experiments with a combination of four blockers
(anandamide, RR, A293, and spermine) demonstrated a signiﬁcant
role of K2P3.1 and K2P9.1 in the RVD of human T cells. The role of
K2P3.1 was also almost independent of the activation status. In case
of K2P9.1 probed with RR and spermine, our volumetric data led to
controversial results. Thus, RR was a more efﬁcient inhibitor of RVD
than spermine in naïve cells, whereas spermine inhibited RVD in stimu-
lated lymphocytes to a higher degree thandid RR (Fig. 5). This discrepan-
cy seems to point to non-speciﬁc side effects of individual blockers (i.e.
RR and spermine), which complicate the analysis of K2P9.1 contribution
to RVD. Nevertheless, the strong RVD inhibition in both cell types by
the highest anandamide concentration (100 μM) indicate an important
role of K2P9.1 in the RVD of human T lymphocytes.3.5. Targeting K2P5.1
As already shown in numerous studies, e.g. [16,29], K2P5.1 is
upregulated in human T cells upon T cell receptor stimulation withCD3/CD28 beads. Moreover, K2P5.1 affects several T cell effector func-
tions, including cytokine production and proliferation [16]. Knock out
studies with K2P5.1 deﬁcient mice have demonstrated the importance
of this channel for volume regulatory mechanisms in murine T cells [3].
The latter ﬁnding is in line with earlier investigations on the role of
K2P5.1 in volume regulation of kidney cells and spermatozoa [30–32]. In
the present study, we used the antiarrhythmic drug quinidine as a
blocker of K2P5.1 [16]. At a concentration of 100 μM, however, quinidine
has also been reported to block K2P18.1 [33].
Treatment of naïve T cells with quinidine at concentrations of
2–20 μM caused an about 75% inhibition of RVD (Fig. 5A). Increasing
quinidine concentration to 100 μM further enhanced the RVD inhibi-
tion to ~85%. These high inhibition rates prove K2P5.1 as one of the
major players in the RVD of naïve T cells. In stimulated T cells, the in-
hibitory capacity of 2–20 μM quinidine (~70%) was similar to that in
naïve cells. But in sharp contrast to the concentration dependence
found in naïve cells, treatment of stimulated cells with the highest
quinidine concentration of 100 μM reduced the extent of RVD inhibi-
tion to ~45%. Possible reasons for the inverse concentration depen-
dence may include a limited blocker solubility and/or its cytotoxic
effects at high quinidine concentrations. Unfortunately, the lack of
more speciﬁc blockers for K2P5.1 complicates studies on this channel.
Nevertheless, the strong inhibition of RVD by lower quinidine
concentrations proves the importance of K2P5.1 for the RVD of
human T lymphocytes.
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Fig. 6. A network of ion channels is involved in the RVD in human CD4+ T lymphocytes. The pathways of electrolyte efﬂux following hypotonic volume increase are displayed. Os-
motic cell swelling causes activation of different potassium channels either mediated by cell membrane potential changes or intracellular Ca2+ level increase (see also Ref. [3]).
KV1.3 and K2P3.1, 5.1 and 9.1 are activated by depolarization of the cell membrane due to swelling activated chloride efﬂux (Clswell). In contrast, K2P18.1 channels have been
demonstrated to be activated by rising intracellular calcium concentrations. Our results indicate a predominant role of members of the K2P channel (red) and 6 transmembrane
domain (6TM) channel families (blue) in RVD of human T cells. The lists below include all potassium channel families and their members known to be involved in volume
regulation. Channels expressed on human lymphocytes are highlighted in black.
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The local anesthetic drug bupivacaine has been found to target sev-
eral K2P channels in a concentration-dependent manner. Bupivacaine
blocks K2P18.1 channels in mice and human cells at micromolar
concentrations (5–80 μM), as shown elsewhere [34]. Bupivacaine
has also been used to block K2P5.1, K2P3.1 and K2P9.1/K2P18.1 channels
at concentrations higher than 17, 40, and 100 μM, respectively
[35–37].
In the present study, the intermediate bupivacaine concentration of
30 μM gave the strongest RVD inhibition of ~75–80% in both cell types.
Either decreasing or increasing the concentration to 3 or 300 μM
considerably reduced the RVD inhibitory capacity of bupivacaine. The
highest concentration of bupivacaine (300 μM) did not cause any RVD
inhibition in stimulated T cells, which might have been due to a poor
blocker solubility in phosphate buffer, denoted by the manufacturer.
The strong inhibitory effect of bupivacaine suggests a signiﬁcant role
of K2P18.1 in the RVD of both naïve and stimulated human T cells. Inagreementwith the protein expression data (Fig. 3I–J), the contribution
of K2P18.1 to the RVD process is independent of the stimulation status.
3.7. Blocking KV1.3 with Strichodactyla helianthus toxin (ShK)
To compare the relative contributions of different potassium chan-
nel families to RVD, we addressed additionally the voltage dependent
potassium channel KV1.3, which is well known to play a key role in a va-
riety of T cell functions, including RVD and T cell effector functions, etc.
[38,39]. In the present study, we used the blocking agent S. helianthus
toxin (ShK), a toxic peptide isolated from the sea anemone. ShK is a
highly potent KV1.3 blocker, capable of inactivating KV1.3 currents,
even in the sub-micromolar range [40,41].
As with murine T lymphocytes studied elsewhere [3], nanomolar
concentrations of ShK (1–100 nM) strongly inhibited RVD in human
T cells (Fig. 5). Despite a nearly 6-fold increased expression of KV1.3
in stimulated cells (Fig. 3J), the blocking effect of ShK was stronger
in naive cells. This ﬁnding suggests a greater relative contribution of
706 J. Andronic et al. / Biochimica et Biophysica Acta 1828 (2013) 699–707KV1.3 to the RVD of the small-sized unstimulated cells, as compared
to the large stimulated T lymphocytes. Increasing ShK concentration
from 1 to 10 nM enhanced the RVD inhibition from ~65 to ~85% in
naïve cells and from ~45 to 65% in stimulated cells. Treatment with
100 nM ShK caused only little further increase in the inhibitory effect.
The concentration dependence of RVD inhibition observed here cor-
roborates the data of previous studies on the blocking KV1.3 currents
with ShK [42].
3.8. Concluding remarks
Extending our previous ﬁndings onmurine cells, the pharmacological
proﬁle of RVD inhibition observed here points to an essential role of K2P
channels in the osmoregulation of human T lymphocytes. Among the
examined K2P channels, K2P5.1 and K2P18.1 seem the most important
for the RVD in T cells, with a smaller contribution of K2P3.1 and K2P9.1.
The impact of K2P5.1 and K2P18.1 on RVD was comparable to that of the
voltage-dependent channel KV1.3, whose signiﬁcance for human T cells
was shown previously [11] and conﬁrmed here (Fig. 5). The pharmaco-
logical proﬁle and thus the impact of potassium channels on the RVD
were found to vary moderately depending on the activation status of T
cells. The variations in general correlated with the stimulation-related
channel expression patterns reported elsewhere [17]. Our results also
underline the heterogeneity of potassium channels involved in the
volume regulation of T cells. As a basic physiological process essential
for cell survival and function, volume regulation in T cells apparently
relies not on a sole potassiumchannel but rather on an interaction ofmul-
tiple cation channels, including partially redundant pathways (see Fig. 6).
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